New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
09:18 EDTAGEN, POZN, ATHX, ABX, FURX, PFE, ETP, HAE, GLW, NEM, SOHU, SUSS, OGXI, YOKU, FRX, BAC, AZNOn The Fly: Pre-market Movers
HIGHER: AstraZeneca (AZN), up 16% after Pfizer (PFE) confirms takeover offer made and turned down by company. Pfizer shares are also up 2.7% as the company says it is still interested in a potential AstraZeneca combination and is weighing its next steps... Furiex (FURX), up 31% after agreeing to be acquired by Forest labs (FRX) for $95 per share and contingent future payments... Susser (SUSS), up 37% after agreeing to be acquired by Energy Transfer Partners (ETP) for approx. $1.8B... Agenus (AGEN), up 10% after announcing collaboration and license agreement with Merck (MRK)... Yokou Toudou (YOKU), up 10% after announcing $1.22B investment led by Alibaba... Corning (GLW), up 2.7% after earnings report. DOWN AFTER EARNINGS: Sohu.com (SOHU), down 6.6%... Haemonetics (HAE), down 9.5%... ALSO LOWER: Bank of America (BAC), down 2.6% after suspending capital actions, including repurchase authorization... Newmont Mining (NEM), down 5.7% after terminating merger discussions with Barrick Gold (ABX)... Athersys (ATHX), down 56% after MultiStem therapy trial fails to show meaningful benefit... OncoGenex (OGXI), down 52% after Synergy did not meet primary endpoint in Phase 3 trial... POZEN (POZN), down 12% after drug candidates PA8140/PA32540 receive Complete Response Letter from FDA.
News For AZN;PFE;BAC;SOHU;FURX;FRX;NEM;ABX;YOKU;GLW;ATHX;OGXI;HAE;POZN;SUSS;ETP;AGEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
May 13, 2015
12:27 EDTSOHUFollow-up: Sohu.com downgraded to Neutral on valuation at JPMorgan
Subscribe for More Information
12:12 EDTSOHUSohu.com downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
09:39 EDTBACActive equity options trading on open
Subscribe for More Information
07:31 EDTPFEHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.
07:29 EDTBACUBS to hold a conference
Subscribe for More Information
May 12, 2015
14:13 EDTBACBove says it may be time to buy bank stocks
Subscribe for More Information
May 11, 2015
19:15 EDTATHXOn The Fly: After Hours Movers
Subscribe for More Information
17:36 EDTPFE, ATHXAthersys down 10.1% after Pfizer notified that it will terminate agreement
Subscribe for More Information
17:34 EDTATHX, PFEAthersys receives notification that Pfizer will terminate agreement
Subscribe for More Information
16:33 EDTPFEPfizer takes minority interest in AM-Pharma, secures option to acquire company
AM-Pharma and Pfizer announced that Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company. The option becomes exercisable upon completion of a Phase II trial of recAP in the treatment of Acute Kidney Injury related to sepsis. There are no drugs currently approved for this condition and the only treatment option is dialysis and supportive care. Results from the current Phase II trial for recAP are expected in the second half of 2016. Under the terms of the agreement, Pfizer has made an upfront payment of $87.5M for the minority equity interest and exclusive option, with additional potential payments of up to $512.5M upon option exercise and potential launch of any product that may result from this agreement. Other terms of the transaction were not disclosed. “Pfizer is committed to advancing the science to address the high unmet medical need in Acute Kidney Injury,” said Mikael Dolsten, M.D., Ph.D., president, Worldwide Research and Development at Pfizer. “Clinical data for recAP show the potential to uniquely address Acute Kidney Injury in the setting of sepsis, and we look forward to working with our partners at AM-Pharma as we aim to accelerate the development of recAP into a potential first-in-class treatment for patients.”
16:27 EDTATHXAthersys reports Q1 EPS (16c), consensus (9c)
Subscribe for More Information
16:00 EDTBACOptions Update; May 11, 2015
Subscribe for More Information
09:58 EDTBACBarclays expected to pay GBP2B to settle forex rigging charges, FT says
Subscribe for More Information
09:37 EDTBACActive equity options trading on open
Subscribe for More Information
08:18 EDTBACBanks executives seek to push back on 'false, damaging' statements, WSJ reports
Subscribe for More Information
May 8, 2015
16:05 EDTBACOptions Update; May 8, 2015
Subscribe for More Information
09:36 EDTBACActive equity options trading on open:
Active equity options trading on open: AAPL BABA FB DIS MSFT TSLA NFLX AMZN BAC
07:32 EDTPOZNPOZEN reports Q1 EPS 0c, one estimate 5c
Subscribe for More Information
06:48 EDTBACBanks to erase debt of bankrupt consumers from reports, NY Times says
Subscribe for More Information
06:35 EDTBACShareholder support for Bank of America board drops, Reuters says
None of the four Bank of America directors up for reelection this week received more than 71.9% of votes, according to Reuters. Last year, none of the directors received less than 98% of votes, the news service stated. Reference Link
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use